As expected, SCOTUS used the BMS case to narrow the rules for the assertion of personal jurisdiction against a defendant.  Bexis provided the short version summary in a June 19, 2017 post at Drug & Device blog. Some defendants will be pleased but others are not pleased. Ditto for lawyers, on both sides. Inevitably, this outcome seems likely to lead to more lawsuits in more states. In turn, that may also lead to more use of AI in order to coordinate between actions. Interesting times ahead.